Emma Walmsley, GlaxoSmithKline CEO (GSK via investor day livestream)
Post-split GSK to exit marquee world HQ, blueprinting smaller corporate digs
Days after GlaxoSmithKline unveiled plans for a major downsizing of its office footprint with plans to exit two iconic US sites, the pharma company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
